A message from Studsvik Scandpower

About Studsvik Scandpower

University of Missouri to expand isotope production with new research reactor

March 27, 2023, 9:31AMNuclear News

Situated in a 30-foot-deep pool, the 10 MW core of MURR is used to irradiate samples and produce isotopes for medical radiopharmaceuticals and research. (Photo: University of Missouri)

The University of Missouri intends to build a new, larger research reactor to produce medical radioisotopes, announcing that it intends to issue a request for qualification/request for proposal (RFQ/RFP) in April to solicit interest from qualified parties to provide preliminary designs and industry partnerships for the new reactor project, called NextGen MURR.

To continue reading, log in or create a free account!

Framatome to produce Lu-177 at Romania’s Cernavoda

November 18, 2024, 9:30AMNuclear News

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at...

TerraPower reaches market-scale production of Ac-225

October 4, 2024, 9:30AMNuclear News

TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the...

QSA Global, Niowave to collaborate on Ac-225 production using Ra-226

August 14, 2024, 3:28PMNuclear News

QSA Global, a provider of radioisotope products, and Niowave, a Michigan-based producer of medical radioisotopes, announced that the companies will codevelop a scalable radium purification...

Missouri radioisotope producer MURR joins European nuclear medicine group

July 22, 2024, 9:30AMNuclear News

The University of Missouri Research Reactor (MURR) is the latest member of Nuclear Medicine Europe, an industry association for the radiopharmaceutical and molecular imaging industry in...

Orano Med inaugurates Pb-212 production facility in Indiana

June 18, 2024, 12:00PMNuclear News

Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated its first ATLab (Alpha Therapy Laboratory) earlier this month. Located in Brownsburg, near...

Oklo’s Diané presents at Community of Practice

June 10, 2024, 7:00AMANS News

The American Nuclear Society’s Risk-informed, Performance-based Principles and Policy Committee (RP3C) held another Community of Practice (CoP) on April 26. For this event, the committee...

Framatome, KHNP to investigate producing Lu-177 in South Korea

April 19, 2024, 7:01AMNuclear News

Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at...

The road to wellness: The task of getting lifesaving medical isotopes to patients

February 2, 2024, 3:01PMNuclear NewsTim Gregoire

According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To ...

Germany’s ITM receives material license to produce Lu-177

January 9, 2024, 12:01PMNuclear News

Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the...

Framatome to work with Romania’s Nuclearelectrica on Lu-177 production

December 4, 2023, 6:58AMNuclear News

Framatome and Nuclearelectrica, operator of Romania’s Cernavoda nuclear power plant, announced the signing of a memorandum of understanding to explore the possibility of producing the...

University of Missouri to expand isotope production with new research reactor

Related Articles